Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities


AKINCI B., Koseoglu F. D., Onay H., Yavuz S., ALTAY C., YILDIRIM ŞİMŞİR I., ...More

METABOLISM-CLINICAL AND EXPERIMENTAL, vol.64, no.9, pp.1086-1095, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 64 Issue: 9
  • Publication Date: 2015
  • Doi Number: 10.1016/j.metabol.2015.06.004
  • Journal Name: METABOLISM-CLINICAL AND EXPERIMENTAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1086-1095
  • Keywords: APL, Diabetes, Hepatic steatosis, Hypertriglyceridemia, Insulin resistance, LEPTIN
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objective. Acquired partial lipodystrophy (APL) is a rare disorder characterized by progressive selective fat loss. In previous studies, metabolic abnormalities were reported to be relatively rare in APL, whilst they were quite common in other types of lipodystrophy syndromes.